| abstract |
The present invention relates to the application of hyperin in the preparation of a medicine for preventing and treating retinal degenerative diseases, wherein the hyperin is a compound having the following structural formula, or a pharmaceutically acceptable salt thereof, Compared with the prior art, the hyperin in the present invention has a significant inhibitory effect on photoreceptor cell death induced by light damage, retinal photoreceptor cell degenerative changes and retinal damage-related immune inflammatory responses, and can significantly treat and improve the retina. Therefore, it can be used to prepare drugs for the treatment of various retinal degenerative diseases including age-related macular degeneration, retinitis pigmentosa, Stargardt disease, cone-rod dystrophy, etc. |